Pharmaqo Labs Dapoxetine 60mg x 50 Tablets: Premature Ejaculation Research Standard
Pharmaqo Labs Dapoxetine 60mg x 50 tablets delivers a precise oral formulation of Dapoxetine, a short-acting selective serotonin reuptake inhibitor (SSRI) specifically developed for research into ejaculatory latency and male sexual function. Originally developed for depression treatment, Dapoxetine was repurposed after demonstrating significant impact on ejaculation timing. Clinical trials report increases in intra-vaginal ejaculatory latency of 200-300%, with some subjects experiencing up to 300% prolongation. Each package contains 50 tablets dosed at 60mg, providing substantial supply for research protocols examining serotonin–mediated control of ejaculatory reflex, sexual satisfaction, and performance anxiety in controlled models.
Dapoxetine reduces worry associated with rapid ejaculation and improves self-confidence and sexual relationship dynamics. The compound is administered 1-3 hours prior to sexual activity, providing acute rather than chronic effects. This on-demand mechanism distinguishes Dapoxetine from daily SSRIs, enabling precise temporal control and reduced cumulative side effect burden. While no universal definition exists, premature ejaculation is generally considered ejaculation occurring within two minutes of penetration. Research utilizing Pharmaqo Labs Dapoxetine 60mg x 50 tablets examines its effects on ejaculatory threshold, perceived control, and overall sexual satisfaction.
The 60mg strength represents the standard research dose, providing optimal efficacy while minimizing adverse effects. The rapid absorption and elimination kinetics enable acute dosing without the accumulation or withdrawal concerns of chronic SSRI administration.
Key Features
- On-Demand Administration: Acute dosing 1-3 hours prior to activity eliminates daily medication burden.
- Rapid Onset: Fast absorption provides timely effects for planned research protocols.
- Short Half-Life: Quick elimination reduces cumulative side effects and drug interactions.
- Efficacy: Clinical trials demonstrate 200–300% increases in ejaculatory latency.
- Control Enhancement: Improved perceived control over ejaculatory reflex.
- Satisfaction Improvement: Increased overall sexual satisfaction and relationship confidence.
- Extended Supply: 50-tablet format supports multiple research sessions.
- Verified Purity Standards: Manufactured under strict pharmaceutical protocols with independent batch testing.
Product Specifications
- Active Ingredient: Dapoxetine Hydrochloride
- Chemical Classification: Short–Acting Selective Serotonin Reuptake Inhibitor (SSRI)
- Dosage Strength: 60mg per tablet
- Pack Size: 50 tablets
- CAS Number: 119356–77-3
- Molecular Formula: C21H23NO · HCl
- Appearance: White to off-white round tablets
- Standard Protocol: 30-60mg taken 1-3 hours prior to activity
- Storage Requirements: Store at 15°C-25°C; protect from light, moisture, and heat
- Shelf Life: 3 years from manufacture date (as indicated on packaging)
- Legal Status: Prescription medication / Research chemical (Regulations vary by jurisdiction)
Mechanism of Action
- SSRI Activity: Blocks serotonin transporters, increasing synaptic serotonin concentration.
- Neurotransmission Modulation: Enhanced serotonergic signaling in central nervous system ejaculatory circuits.
- Ejaculatory Reflex Inhibition: Increased serotonin elevates ejaculatory threshold and delays reflex.
- 5-HT2C Receptor Activation: Specific serotonin receptor subtype implicated in ejaculatory control.
- Rapid Absorption: Peak plasma concentrations achieved within 1-2 hours of administration.
- Quick Elimination: Short half-life of approximately 1.5 hours enables on-demand use without accumulation.
Metabolic Impact
Research utilizing Pharmaqo Labs Dapoxetine 60mg x 50 tablets reveals significant physiological effects:
- Ejaculatory Latency: Significant prolongation of intra-vaginal time to ejaculation.
- Control Perception: Enhanced subjective sense of control over ejaculatory timing.
- Distress Reduction: Decreased anxiety and worry related to sexual performance.
- Satisfaction Enhancement: Improved sexual satisfaction for subjects and partners.
- Relationship Quality: Positive impact on sexual relationship dynamics and confidence.
- Cardiovascular Parameters: Minimal impact on blood pressure or heart rate at therapeutic doses.
- Neurological Effects: Transient dizziness, headache, or nausea in some subjects.
Where to Buy Pharmaqo Labs Dapoxetine 60mg x 50 Tablets
Acquiring genuine Pharmaqo Labs Dapoxetine 60mg x 50 tablets requires sourcing from authorized distributors to ensure authenticity and safety.
- Authorized Suppliers Only: Purchase exclusively from verified Pharmaqo Labs distributors with documented authorization.
- Batch Verification: Verify unique batch codes through official Pharmaqo Labs channels before use.
- Visual Inspection: Authentic packaging features professional labeling, intact seals, and uniform tablets free of defects.
- Avoid Unverified Sources: Do not purchase from social media, underground forums, or vendors lacking proof of authenticity.
Conclusion
Pharmaqo Labs Dapoxetine 60mg x 50 tablets represents a specialized research tool for investigators examining serotonergic control of ejaculatory function and male sexual physiology. The unique short-acting SSRI profile enables on-demand administration without the accumulation, withdrawal, or chronic side effect concerns of traditional antidepressants. The 60mg optimized dose and 50-tablet extended supply support comprehensive protocols investigating ejaculatory latency, perceived control, and sexual satisfaction outcomes. The rapid absorption and elimination kinetics provide precise temporal control, distinguishing Dapoxetine from daily SSRI alternatives. Clinical evidence demonstrating 200-300% increases in ejaculatory latency establishes robust foundation for research applications.




Reviews
There are no reviews yet.